![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, April 22, 2018 8:16:03 AM
There is ZERO proof that OMHE is even doing any kind of research.
IMO, they're not "fast-tracking" anything.
That was a PR ploy. OMHE has never brought a single prescription med from incubation to human/animal trials to FDA approval to commercial/retail prescription sales.
There is ZERO evidence that any of the OMHE researchers have ever successfully developed a single prescription medication from incubation to market. Zero evidence.
Why would they PR the "fast track" buzzword? because no trader wants to hear that the average is closer to 12 years.
The time window of 3 years "fast track" buys OMHE insiders 3 years worth of time to compensate themselves.
So far, almost $1 mil compensated to insiders for the first two quarters of the current FY.
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM